App note: recombinant antibody formats, expressions & applications

Laboratory research

Advancements in antibody engineering technologies have greatly enhanced the generation of recombinant antibodies in various formats as therapeutic agents.

There are already more than 100 antibody-based drugs approved by the FDA, and numerous antibodies are currently in their late-stage clinical studies.

Compared to monoclonal antibodies produced using traditional hybridoma techniques, recombinant antibodies offer advantages, such as high lot-to-lot consistency, animal-free manufacturing, engineering advancement possibilities, and continuous supply. Given the importance, recombinant antibodies are becoming indispensable tools for basic research, diagnostics, and clinical applications.

Download this app note from Sino Biological to learn more about:

The formats, expressions, and applications of these recombinant antibodies:

  • Chimeric Antibodies
  • Antibody Fragments
  • Bispecific Antibodies
  • Fc-Fusion Proteins

Download here



Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free